Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance

Cell Metabolism

Volumn 10, Issue 5, 2009, Pages 405-418

  Leavens, Karla F ^a   Easton, Rachael M ^a   Shulman, Gerald I ^b   Previs, Stephen F ^c   Birnbaum, Morris J ^a  

^a Institute for Diabetes   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HUMDISEASE

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LEPTIN; LIPID; PROTEIN KINASE B BETA; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE MODEL; FATTY ACID SYNTHESIS; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

ANIMALS; DIETARY FATS; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; MICE, OBESE; OBESITY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TRIGLYCERIDES;

MUS;

EID: 70350417158     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.10.004     Document Type: Article

References (54)

1. Biddinger S.B., Hernandez-Ono A., Rask-Madsen C., Haas J.T., Aleman J.O., Suzuki R., Scapa E.F., Agarwal C., Carey M.C., Stephanopoulos G., et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 7 (2008) 125-134
2. Bray G.A., and York D.A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59 (1979) 719-809
3. Brown M.S., and Goldstein J.L. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7 (2008) 95-96
4. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114 (2004) 147-152
5. Brunengraber D.Z., McCabe B.J., Kasumov T., Alexander J.C., Chandramouli V., and Previs S.F. Influence of diet on the modeling of adipose tissue triglycerides during growth. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E917-E925
6. Chen W.S., Xu P.Z., Gottlob K., Chen M.L., Sokol K., Shiyanova T., Roninson I., Weng W., Suzuki R., Tobe K., et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15 (2001) 2203-2208
7. Chen W.S., Peng X.D., Wang Y., Xu P.Z., Chen M.L., Luo Y., Jeon S.M., Coleman K., Haschek W.M., Bass J., et al. Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Mol. Cell Biol. 29 (2009) 3151-3162
8. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw III E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., and Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 (2001) 1728-1731
9. Cho H., Thorvaldsen J.L., Chu Q., Feng F., and Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276 (2001) 38349-38352
10. Dentin R., Benhamed F., Hainault I., Fauveau V., Foufelle F., Dyck J.R., Girard J., and Postic C. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55 (2006) 2159-2170
11. Diraison F., Pachiaudi C., and Beylot M. Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J. Mass Spectrom. 32 (1997) 81-86
12. Diraison F., Moulin P., and Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29 (2003) 478-485
13. Dong X.C., Copps K.D., Guo S., Li Y., Kollipara R., DePinho R.A., and White M.F. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8 (2008) 65-76
14. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., and Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 (2005) 1343-1351
15. Doria A., Patti M.E., and Kahn C.R. The emerging genetic architecture of type 2 diabetes. Cell Metab. 8 (2008) 186-200
16. Easton R.M., Cho H., Roovers K., Shineman D.W., Mizrahi M., Forman M.S., Lee V.M., Szabolcs M., de Jong R., Oltersdorf T., et al. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 25 (2005) 1869-1878
17. Fleischmann M., and Iynedjian P.B. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem. J. 349 (2000) 13-17
18. Garofalo R.S., Orena S.J., Rafidi K., Torchia A.J., Stock J.L., Hildebrandt A.L., Coskran T., Black S.C., Brees D.J., Wicks J.R., et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 112 (2003) 197-208
19. Gross D.N., van den Heuvel A.P., and Birnbaum M.J. The role of FoxO in the regulation of metabolism. Oncogene 27 (2008) 2320-2336
20. Hegarty B.D., Bobard A., Hainault I., Ferre P., Bossard P., and Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc. Natl. Acad. Sci. USA 102 (2005) 791-796
21. Horie Y., Suzuki A., Kataoka E., Sasaki T., Hamada K., Sasaki J., Mizuno K., Hasegawa G., Kishimoto H., Iizuka M., et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113 (2004) 1774-1783
22. Koo S.H., Dutcher A.K., and Towle H.C. Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver. J. Biol. Chem. 276 (2001) 9437-9445
23. Kubota N., Kubota T., Itoh S., Kumagai H., Kozono H., Takamoto I., Mineyama T., Ogata H., Tokuyama K., Ohsugi M., et al. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab. 8 (2008) 49-64
24. Lee W.N., Bassilian S., Ajie H.O., Schoeller D.A., Edmond J., Bergner E.A., and Byerley L.O. In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. Am. J. Physiol. 266 (1994) E699-E708
25. Lee W.N., Bassilian S., Guo Z., Schoeller D., Edmond J., Bergner E.A., and Byerley L.O. Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis. Am. J. Physiol. 266 (1994) E372-E383
26. Li X., Monks B., Ge Q., and Birnbaum M.J. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447 (2007) 1012-1016
27. Matsumoto M., Ogawa W., Teshigawara K., Inoue H., Miyake K., Sakaue H., and Kasuga M. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51 (2002) 1672-1680
28. Matsumoto M., Ogawa W., Akimoto K., Inoue H., Miyake K., Furukawa K., Hayashi Y., Iguchi H., Matsuki Y., Hiramatsu R., et al. PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112 (2003) 935-944
29. Matsumoto M., Pocai A., Rossetti L., Depinho R.A., and Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6 (2007) 208-216
30. Matsusue K., Kusakabe T., Noguchi T., Takiguchi S., Suzuki T., Yamano S., and Gonzalez F.J. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 7 (2008) 302-311
31. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258 (1992) 766-770
32. Neschen S., Morino K., Hammond L.E., Zhang D., Liu Z.X., Romanelli A.J., Cline G.W., Pongratz R.L., Zhang X.M., Choi C.S., et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2 (2005) 55-65
33. Ono H., Shimano H., Katagiri H., Yahagi N., Sakoda H., Onishi Y., Anai M., Ogihara T., Fujishiro M., Viana A.Y., et al. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52 (2003) 2905-2913
34. Petersen K.F., Laurent D., Rothman D.L., Cline G.W., and Shulman G.I. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J. Clin. Invest. 101 (1998) 1203-1209
35. Petersen K.F., Dufour S., Befroy D., Lehrke M., Hendler R.E., and Shulman G.I. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608
36. Petersen K.F., Dufour S., Savage D.B., Bilz S., Solomon G., Yonemitsu S., Cline G.W., Befroy D., Zemany L., Kahn B.B., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 104 (2007) 12587-12594
37. Porstmann T., Griffiths B., Chung Y.L., Delpuech O., Griffiths J.R., Downward J., and Schulze A. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24 (2005) 6465-6481
38. Postic C., and Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118 (2008) 829-838
39. Postic C., and Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab. 34 (2008) 643-648
40. Postic C., Dentin R., Denechaud P.D., and Girard J. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu. Rev. Nutr. 27 (2007) 179-192
41. Raghow R., Yellaturu C., Deng X., Park E.A., and Elam M.B. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol. Metab. 19 (2008) 65-73
42. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
43. Savage D.B., Petersen K.F., and Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87 (2007) 507-520
44. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., and Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 278 (2003) 9013-9018
45. Semple R.K., Sleigh A., Murgatroyd P.R., Adams C.A., Bluck L., Jackson S., Vottero A., Kanabar D., Charlton-Menys V., Durrington P., et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J. Clin. Invest. 119 (2009) 315-322
46. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274 (1999) 30028-30032
47. Shimomura I., Matsuda M., Hammer R.E., Bashmakov Y., Brown M.S., and Goldstein J.L. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6 (2000) 77-86
48. Song S., Zhang Y., Ma K., Jackson-Hayes L., Lavrentyev E.N., Cook G.A., Elam M.B., and Park E.A. Peroxisomal proliferator activated receptor gamma coactivator (PGC-1alpha) stimulates carnitine palmitoyltransferase I (CPT-Ialpha) through the first intron. Biochim. Biophys. Acta 1679 (2004) 164-173
49. Stiles B., Wang Y., Stahl A., Bassilian S., Lee W.P., Kim Y.J., Sherwin R., Devaskar S., Lesche R., Magnuson M.A., and Wu H. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc. Natl. Acad. Sci. USA 101 (2004) 2082-2087
50. Surwit R.S., Feinglos M.N., Rodin J., Sutherland A., Petro A.E., Opara E.C., Kuhn C.M., and Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44 (1995) 645-651
51. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
52. Taniguchi C.M., Kondo T., Sajan M., Luo J., Bronson R., Asano T., Farese R., Cantley L.C., and Kahn C.R. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab. 3 (2006) 343-353
53. Williams K.J. Molecular processes that handle-and mishandle-dietary lipids. J. Clin. Invest. 118 (2008) 3247-3259
54. Yahagi N., Shimano H., Hasty A.H., Matsuzaka T., Ide T., Yoshikawa T., Amemiya-Kudo M., Tomita S., Okazaki H., Tamura Y., et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J. Biol. Chem. 277 (2002) 19353-19357